Literature DB >> 12213784

Dermatan sulfate: new functions from an old glycosaminoglycan.

Janet M Trowbridge1, Richard L Gallo.   

Abstract

Glycosaminoglycans constitute a considerable fraction of the glycoconjugates found on cellular membranes and in the extracellular matrix of virtually all mammalian tissues. Their ability to bind and alter protein-protein interactions or enzymatic activity has identified them as important determinants of cellular responsiveness in development, homeostasis, and disease. Although heparan sulfate tends to be emphasized as the most biologically active glycosaminoglycan, dermatan sulfate is a particularly attractive subject for further study because it is expressed in many mammalian tissues and it is the predominant glycan present in skin. Dermatan and dermatan sulfate proteoglycans have also been implicated in cardiovascular disease, tumorigenesis, infection, wound repair, and fibrosis. Growing evidence suggests that this glycosaminoglycan, like the better studied heparin and heparan sulfate, is an important cofactor in a variety of cell behaviors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213784     DOI: 10.1093/glycob/cwf066

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  105 in total

1.  End-functionalized glycopolymers as mimetics of chondroitin sulfate proteoglycans.

Authors:  Song-Gil Lee; Joshua M Brown; Claude J Rogers; John B Matson; Chithra Krishnamurthy; Manish Rawat; Linda C Hsieh-Wilson
Journal:  Chem Sci       Date:  2010-09-01       Impact factor: 9.825

2.  Dermatan sulfate interacts with dead cells and regulates CD5(+) B-cell fate: implications for a key role in autoimmunity.

Authors:  Julia Y Wang; Jongmin Lee; Ming Yan; Jung-hyun Rho; Michael H A Roehrl
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 3.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

4.  Enhanced PAPSS2/VCAN sulfation axis is essential for Snail-mediated breast cancer cell migration and metastasis.

Authors:  Yihong Zhang; Xiuqun Zou; Wenli Qian; Xiaoling Weng; Lin Zhang; Liang Zhang; Shuang Wang; Xuan Cao; Li Ma; Gang Wei; Yingjie Wu; Zhaoyuan Hou
Journal:  Cell Death Differ       Date:  2018-06-28       Impact factor: 15.828

Review 5.  Growth impairment in mucopolysaccharidoses.

Authors:  Melodie Melbouci; Robert W Mason; Yasuyuki Suzuki; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-03-16       Impact factor: 4.797

6.  Tandem mass spectrometric strategies for determination of sulfation positions and uronic acid epimerization in chondroitin sulfate oligosaccharides.

Authors:  Joseph Zaia; Xue-Qing Li; Shiu-Yung Chan; Catherine E Costello
Journal:  J Am Soc Mass Spectrom       Date:  2003-11       Impact factor: 3.109

7.  Biochemical characterization of the chondroitinase ABC I active site.

Authors:  Vikas Prabhakar; Rahul Raman; Ishan Capila; Carlos J Bosques; Kevin Pojasek; Ram Sasisekharan
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

8.  Plasmodium falciparum ookinetes require mosquito midgut chondroitin sulfate proteoglycans for cell invasion.

Authors:  Rhoel R Dinglasan; Aditi Alaganan; Anil K Ghosh; Akio Saito; Toin H van Kuppevelt; Marcelo Jacobs-Lorena
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

9.  Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome.

Authors:  Munis Dündar; Thomas Müller; Qi Zhang; Jing Pan; Beat Steinmann; Julia Vodopiutz; Robert Gruber; Tohru Sonoda; Birgit Krabichler; Gerd Utermann; Jacques U Baenziger; Lijuan Zhang; Andreas R Janecke
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

Review 10.  Chondroitin sulfate/dermatan sulfate sulfatases from mammals and bacteria.

Authors:  Shumin Wang; Kazuyuki Sugahara; Fuchuan Li
Journal:  Glycoconj J       Date:  2016-08-15       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.